Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05073419Not ApplicableRecruiting

Arrhythmia Detection After MI

Role: lead

NCT03031847Not ApplicableCompleted

Cardiac Resynchronization in the Elderly

Role: lead

NCT04128878Completed

Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients

Role: lead

NCT00156390Not ApplicableCompleted

Predictors of Response to Biventricular Pacing in Heart Failure

Role: lead

All 4 trials loaded